The AKT inhibitor Capivasertib (AZD5363): From Discovery to Clinical Proof of Concept – Dr Barry Davies – Director, Clinical and Translational Scientific Alliances, AstraZeneca

When:
July 18, 2019 @ 9:30 am – 10:30 am
2019-07-18T09:30:00+01:00
2019-07-18T10:30:00+01:00
Where:
Clinical School Lecture Theatre 2
Contact:
Louisa Bellis

Abstract not available